These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15489577)

  • 1. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study.
    Ochsenkühn T; Sackmann M; Göke B
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1167-71. PubMed ID: 15489577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
    Sands BE; Tremaine WJ; Sandborn WJ; Rutgeerts PJ; Hanauer SB; Mayer L; Targan SR; Podolsky DK
    Inflamm Bowel Dis; 2001 May; 7(2):83-8. PubMed ID: 11383595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
    Lawson MM; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
    Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of ulcerative colitis refractory to intravenous cyclosporine therapy successfully treated with infliximab].
    Tsuya R; Motoya S; Tanaka H; Nakagaki S; Nishioka H; Hagiwara T; Kozawa H; Kurokawa S; Ambo T; Imamura A
    Nihon Shokakibyo Gakkai Zasshi; 2008 May; 105(5):679-85. PubMed ID: 18460856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and clinical perspectives for the use of infliximab in ulcerative colitis.
    Panaccione R; Fedorak RN; Aumais G; Bernard EJ; Bernstein CN; Bitton A; Croitoru K; Dieleman LA; Enns R; Feagan BG; Franchimont D; Greenberg GR; Griffiths AM; Marshall JK; Pare P; Patel S; Penner R; Render C; Seidman E; Steinhart AH
    Can J Gastroenterol; 2008 Mar; 22(3):261-72. PubMed ID: 18354755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab is effective in acute but not chronic childhood ulcerative colitis.
    Russell GH; Katz AJ
    J Pediatr Gastroenterol Nutr; 2004 Aug; 39(2):166-70. PubMed ID: 15269622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in severe steroid-refractory ulcerative colitis: a pilot study.
    Kaser A; Mairinger T; Vogel W; Tilg H
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):930-3. PubMed ID: 11802508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
    Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Danielsson A; Verbaan H; Hellström PM; Magnuson A; Curman B
    Gastroenterology; 2005 Jun; 128(7):1805-11. PubMed ID: 15940615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.
    Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M
    Dig Liver Dis; 2002 Sep; 34(9):626-30. PubMed ID: 12405248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.
    Probert CS; Hearing SD; Schreiber S; Kühbacher T; Ghosh S; Arnott ID; Forbes A
    Gut; 2003 Jul; 52(7):998-1002. PubMed ID: 12801957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
    Vande Casteele N; Ferrante M; Van Assche G; Ballet V; Compernolle G; Van Steen K; Simoens S; Rutgeerts P; Gils A; Vermeire S
    Gastroenterology; 2015 Jun; 148(7):1320-9.e3. PubMed ID: 25724455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.